[SGMO] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
13-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -34.09%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 176,232 111,299 110,701 118,192 102,428 84,452 36,567 29.95%
PBT -262,903 -191,849 -177,991 -120,777 -95,419 -68,889 -54,568 29.94%
Tax -5,072 429 306 345 -19,601 8,261 -1,498 22.52%
NP -257,831 -192,278 -178,297 -121,122 -75,818 -68,334 -54,568 29.52%
Tax Rate - - - - - - - -
Total Cost 434,063 303,577 288,998 239,314 178,246 152,786 91,135 29.69%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -146.30 -172.76 -161.06 -102.48 -74.02 -80.91 -149.23 -0.32%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.48 -1.25 -1.23 -0.90 -0.68 -0.70 -0.70 13.28%
EPS Diluted -1.48 -1.25 -1.23 -0.90 -0.68 -0.70 -0.70 13.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.